Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Pathogenesis of Retinal Vascular Diseases Based on Body Fluid Metabolomics

NCT06408571 is registered in ClinicalTrials.gov with Zhongnan Hospital as lead sponsor.

NCT NCT06408571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06408571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Pathogenesis of Retinal Vascular Diseases Based on Body Fluid Metabolomics
Lead sponsor
Zhongnan Hospital
Phase
Observational
Overall status
Unknown status
Start date
September 7, 2023
Completion date
December 30, 2024
Enrollment
3,900 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolomics; retinopathy; etiology